Muscle triglycerides and mitochondrial function: Possible mechanisms for the development of type 2 diabetes

International Journal of Obesity

Volumn 29, Issue , 2005, Pages S111-S115

  Roden, M ^a  

^a HANUSCH HOSPITAL   (Austria)

Author keywords

Fat; Glucose oxidation; Lipotoxicity; Skeletal muscel

Indexed keywords

ACYL COENZYME A; ADENOSINE TRIPHOSPHATE; FATTY ACID; GLUCOSE; GLYCOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MATRIX METALLOPROTEINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE C; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIOGENESIS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; GENETIC RISK; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HEREDITY; HUMAN; INFLAMMATION; LIPID DIET; MALE; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE PHOSPHORYLATION; PHOSPHORYLATION; PRIORITY JOURNAL; RELATIVE;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY FATS; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; MITOCHONDRIA, MUSCLE; TRIGLYCERIDES;

EID: 33644972032     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803102     Document Type: Article

References (33)

1. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among US adolescents, 1999–2000. Diabetes Care 2004; 27: 2438–2443.
2. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362–2374.
3. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346: 802–810.
4. Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, Boselli L, Barbetta G, Allen K, Rife F, Savoye M, Dziura J, Sherwin R, Shulman GI, Caprio S. Prediabetes in obese youth: A syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003; 362: 951–957.
5. Krssak M, Petersen KF, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, Shulman GI. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A 1H NMR spectroscopy study. Diabetologia 1999; 42: 113–116.
6. Perseghin G, Scifo P, De Cobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, Del Maschio A, Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: A 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999; 48: 1600–1606.
7. Kautzky-Willer A, Krssak M, Winzer C, Pacini G, Tura A, Serdat F, Wagner OF, Brabant G, Horn R, Stingl H, Waldhäusl W, Roden M. Increased intramyocellular lipid concentrations identify impaired glucose and energy metabolism in women with prior gestational diabetes. Diabetes 2003; 52: 244–251.
8. Roden M. Non-invasive studies of glycogen metabolism in human skeletal muscle using magnetic resonance spectroscopy. Curr Opin Clin Nutr Metab Care 2001; 4: 26–266.
9. Perseghin G, Price TB, Falk Petersen K, Roden M, Cline GW, Gerow K, Rothman DL, Shulman GI. Increased glucose transportphosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 1996; 335: 1357–1362.
10. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 664–671.
11. Lazar MA. How obesity causes diabetes: Not a tall tale. Science 2005; 307: 373–375.
12. Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O. Mutation analysis of peroxysome proliferators-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia 2001; 44: 2220–2226.
13. Roden M. How free fatty acids inhibit glucose utilization in human skeletal muscle. News Physiol Sci 2004; 19: 92–96.
14. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997; 46: 3–10.
15. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97: 2859–2865.
16. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Fürnsinn C, Moser E, Waldhäusl W. Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans. Diabetes 1999; 48: 358–364.
17. Krebs M, Krssak M, Nowotny P, Weghuber D, Gruber S, Mlynarik V, Bischof M, Stingl H, Fürnsinn C, Waldhäusl W, Roden M. Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6-phosphate concentration in humans. J Clin Endocrinol Metab 2001; 86: 2153–2160.
18. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999; 103: 253–259.
19. Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001; 50: 1612–1617.
20. Brehm A, Krssak M, Schmid AI, Nowotny P, Waldhäusl W, Roden M. Increased lipid availability impairs insulin stimulated ATP synthesis im human skeletal muscle. Diabetes 2005; 54: A381.
21. Stump CS, Short KR, Bigelow ML, Schimke JM, Nair KS. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci USA 2003; 100: 7996–8001.
22. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, DeFronzo R, Cusi K. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 2005; 54: 1640–1648.
23. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002; 51: 2005–2011.
24. Richardson DK, Kashyap S, Bajaj M, Cusi K, Mandarino SJ, Finlayson J, Defronzo RA, Jenkinson CP, Mandarino LJ. Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases expression of extracellular matrix genes in human skeletal muscle. J Biol Chem 2005; 280: 10290–10297.
25. Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, Smith SR. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005; 54: 1926–1933.
26. Clore JN, Li J, Gill R, Gupta S, Spencer R, Azzam A, Zuelzer W, Rizzo WB, Blackard WG. Skeletal muscle phosphatidylcholine fatty acids and insulin sensitivity in normal humans. Am J Physiol 1998; 275: E665–E670.
27. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005; 54: 8–14.
28. Kelley DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: A reexamination. Diabetes 2000; 49: 677–683.
29. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, Mandarino LJ. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003; 100: 8466–8471.
30. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267–273.
31. Patti ME, Kahn BB. Nutrient sensor links obesity with diabetes risk. Nat Med 2005; 10: 1049–1050.
32. Tremblay F, Krebs M, Dombrowski L, Brehm A, Bernroider E, Roth E, Nowotny P, Waldhäusl W, Marette A, Roden M. Overactivation of S6K1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 2005; 54: 2674–2684.
33. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 2003; 300: 1140–1142.